Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis.

Pubmed ID: 12089671

Journal: The Journal of infectious diseases

Publication Date: July 1, 2002

MeSH Terms: Humans, Male, Adult, HIV Infections, Acquired Immunodeficiency Syndrome, Middle Aged, Genotype, Prospective Studies, Cytomegalovirus, Viral Envelope Proteins, AIDS-Related Opportunistic Infections, Cytomegalovirus Retinitis

Grants: N01-HB-57115, N01-HB-57127

Authors: Kalish LA, Busch MP, Drew WL, Chou S, Mohr BA, Miner RC, Asmuth DM, van der Horst CM

Cite As: Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, van der Horst CM, Asmuth DM, Kalish LA. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis 2002 Jul 1;186(1):114-7. Epub 2002 May 22.

Studies:

Abstract

Cytomegalovirus (CMV) strains may be categorized into 4 different groups on the basis of glycoprotein B (gB) genotype. gB genotypes in CMV polymerase chain reaction (PCR)-positive samples from case patients who were diagnosed with retinitis during prospective follow-up were compared with genotypes in CMV PCR-positive samples from an equal number of retinitis-free matched control subjects. All patients were infected with human immunodeficiency virus (HIV) and CMV. Control subjects and their plasma samples were matched with case patients according to baseline CD4(+) T cell count, transfusion history, HIV risk factor, and follow-up time. CMV DNA was genotyped by restriction-enzyme digestion. Eighteen patients met our case definition. Approximately one-third of patients had gB genotype 1, and half had gB genotype 2. These rates were similar among case patients and control subjects and were similar by risk group. The CMV gB2 genotype is not a major determinant of retinitis pathogenicity but appears to be highly prevalent among HIV-infected patients.